News

IICT transfers Favipiravir production process to Cipla; develops low cost Covid-19 test kit

Indian Institute of Chemical Technology has developed a cost-effective synthetic process for producing antiviral drug Favipiravir and has also developed an affordable RT-PCR kit.

May 05, 2020

By : Team ABLE

Glenmark receives DCGI approval to conduct trials in India on Favipiravir antiviral tablets for COVID-19 patients

The product is a generic version of Avigan of Fujifilm Toyama. Favipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections.

May 05, 2020

By : Team ABLE

COVID-19 testing lab opens at IISc

The BSL-3 lab will start operations as soon as patient samples are dispatched to the laboratory by the Department of Health and Family Welfare.

May 05, 2020

By : Team ABLE

IISc team designs indigenous ventilator prototype for COVID-19 patients

Engineers at the Indian Institute of Science (IISc) is currently building a prototype of an electro-mechanical ventilator from scratch, using only components found or made in India

May 04, 2020

By : Team ABLE

IIT M-incubated startup develops nanoparticle coating material to ‘inactivate’ Coronavirus on contact

Using Muse wearables’ coating machine, nanoparticles-based Antimicrobial agents can be coated on textiles, which can be used for N95, surgical masks, PPE equipment and food packaging bags

May 04, 2020

By : Team ABLE